Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
Go back to Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection| Cocrystal Pharma, Inc. (NASDAQ: COCP) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $0.92 | |||
| Open | $1.00 | 52 Week Low | $0.32 | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $-0.18 | |||
| Volume | 104,325 | |||||
